.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Teva
Express Scripts
Accenture
Harvard Business School
Citi
Covington
Healthtrust
UBS

Generated: June 22, 2017

DrugPatentWatch Database Preview

PAVULON Drug Profile

« Back to Dashboard

What is the patent landscape for Pavulon, and what generic Pavulon alternatives are available?

Pavulon is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in PAVULON is pancuronium bromide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pancuronium bromide profile page.

Summary for Tradename: PAVULON

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list33
Patent Applications: see list1,462
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PAVULON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
PAVULON
pancuronium bromide
INJECTABLE;INJECTION017015-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Organon Usa Inc
PAVULON
pancuronium bromide
INJECTABLE;INJECTION017015-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PAVULON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
PAVULON
pancuronium bromide
INJECTABLE;INJECTION017015-002Approved Prior to Jan 1, 19823,553,212► Subscribe
Organon Usa Inc
PAVULON
pancuronium bromide
INJECTABLE;INJECTION017015-001Approved Prior to Jan 1, 19823,553,212► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Moodys
Novartis
Johnson and Johnson
Chinese Patent Office
Merck
Dow
Mallinckrodt
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot